Reliability and Validity of the Selective Control of the Upper Extremity Scale in Stroke Patients
1 other identifier
observational
44
1 country
1
Brief Summary
Selective motor control is defined as the ability to perform the movement in isolation without revealing movement in another joint, without mirror movements, without using a flexor or extensor pattern in the extremities during a desired movement in one joint. Evaluation of selective motor control is important to predict future functional status in adult stroke patients. The Fugl-Meyer Upper Extremity Motor Rating Scale is the basic test in the assessment of motor functions in stroke patients. However, this test is a complicated scale and it takes more than one hour to complete the rating of the patient; Physicians without experience cannot perform the test because it is difficult. This planned study aims to demonstrate the validity and reliability of Selective Control of the Upper Extremity Scale (SCUES) in the evaluation of selective motor control of upper extremity in stroke patients; thus, it aims to present SCUES to medical professionals as a practical clinical tool to be used in stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 24, 2022
CompletedFirst Submitted
Initial submission to the registry
November 25, 2022
CompletedFirst Posted
Study publicly available on registry
December 6, 2022
CompletedDecember 6, 2022
November 1, 2022
8 months
November 25, 2022
November 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Selective Control of the Upper Extremity Scale (SCUES)
The SCUES is a video-based assessment tool that evaluates selective movements of shoulder, elbow, forearm, wrist, and fingers bilaterally.The test is performed as follows. The child is seated at a table front of the camera. The examiner demonstrates the desired movements to the child, and then passively moves the joint to represent the desired movement. The child is then asked to perform the desired movement actively. The video camera is placed in front of the participant from frontal plane. Selective voluntary motor control (SVMC) is scored as normal SVMC (3 points), mildly diminished SVMC (2 points), moderately diminished SVMC (1 point), and no SVMC (0 points) for each joint. The degree of SVMC is determined by the presence of 4 characteristics (movement in joints other than target joint, mirror movements, trunk movements, observed movement less than passive range of motion).The score of each joint is summed up to a maximum of 15 points per limb.
15 min
Eligibility Criteria
Patients with a diagnosis of hemiplegia as a result of ischemic or hemorrhagic stroke documented by cranial CT or MRI, followed for at least 6 months, aged between 18-75 years, with upper extremity involvement and their Brunnstrom upper extremity staging is in between1-6.
You may qualify if:
- Being between the ages of 18-75
- History of unilateral ischemic or hemorrhagic stroke documented by cranial CT or MRI
- At least 6 months have passed since the stroke
- Upper extremity involvement between Brunnstrom stages 1 and 6
- To be voluntarily accepting the process
You may not qualify if:
- Presence of additional diseases with progressive neurological deficit such as multiple sclerosis, amyotrophic lateral sclerosis
- Having additional muscle disease
- History of previous upper extremity surgery
- Botulinum toxin for spasticity treatment in the last 3 months
- Active localized or systemic infection
- Presence of diagnosed lymphedema in the upper extremities
- Having other neurological disorder affecting the upper extremity like brachial plexopathy etc.
- History of malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, Atasehir, 34752, Turkey (Türkiye)
Related Publications (3)
Wagner LV, Davids JR, Hardin JW. Selective Control of the Upper Extremity Scale: validation of a clinical assessment tool for children with hemiplegic cerebral palsy. Dev Med Child Neurol. 2016 Jun;58(6):612-7. doi: 10.1111/dmcn.12949. Epub 2015 Nov 3.
PMID: 26526592BACKGROUNDTuncdemir M, Karakaya J, Kerem-Gunel M. Reliability and Validity of the Turkish Version of the Selective Control of the Upper Extremity Scale in Children with Cerebral Palsy. Phys Occup Ther Pediatr. 2022;42(1):99-112. doi: 10.1080/01942638.2021.1928809. Epub 2021 May 24.
PMID: 34030602BACKGROUNDLieber J, Gartmann T, Keller JW, van Hedel HJA. Validity and reliability of the Selective Control of the Upper Extremity Scale in children with upper motor neuron lesions. Disabil Rehabil. 2022 Jul;44(14):3694-3700. doi: 10.1080/09638288.2021.1881171. Epub 2021 Feb 12.
PMID: 33577357BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2022
First Posted
December 6, 2022
Study Start
February 1, 2022
Primary Completion
September 15, 2022
Study Completion
October 24, 2022
Last Updated
December 6, 2022
Record last verified: 2022-11